Lee W Y, Sehon A H
J Immunol. 1975 Feb;114(2 pt 2):829-36.
Reaginic antibodies to DNP and ovalbumin were indcued readily in B6D2F1 mice by a single intraperitoneal injection of 1 mug of DNP-ovalbumin suspended with 1 mg aluminum hydroxide in 0.5 ml of saline. The formation of anti-DNP reaginic antibody was completely suppressed by treatment of mice with a conjugate consisting of the hapten coupled to an isolgous nonimmunogenic carrier, viz., murine phi-globulins. However, this treatment did not affect the level of antibody formation to the carrier of the immunizing antigen. The induction of unresponsiveness was dose dependent, complete suppression being achieved with 1 mg of the tolerogen. The state of unresponsiveness could be maintained for prolonged periods (these observations were made over a period of at least 8 months) by repeated injections of the tolerogen at intervals of 2 months. More importantly, the state of unresponsiveness could be induced readily not only in normal, but also in sensitized mice, i.e., this treatment was capable of abrogating an ongoing reaginic response, and the suppression was immunologically specific. Hence this system appears to have a great potential for adaptation to the treatment of allergic diseases in man.
通过在0.5毫升盐水中将1微克二硝基苯 - 卵白蛋白与1毫克氢氧化铝悬浮后单次腹腔注射,可在B6D2F1小鼠中轻易诱导出针对二硝基苯(DNP)和卵白蛋白的反应素抗体。用由半抗原与同种非免疫原性载体(即鼠类φ球蛋白)偶联而成的缀合物处理小鼠,可完全抑制抗DNP反应素抗体的形成。然而,这种处理并不影响针对免疫抗原载体的抗体形成水平。无反应性的诱导呈剂量依赖性,1毫克耐受原可实现完全抑制。通过每隔2个月重复注射耐受原,无反应状态可维持较长时间(这些观察是在至少8个月的时间段内进行的)。更重要的是,不仅在正常小鼠中,而且在致敏小鼠中都能轻易诱导出无反应状态,即这种处理能够消除正在进行的反应素反应,并且这种抑制具有免疫特异性。因此,该系统似乎具有很大的潜力可用于人类过敏性疾病的治疗。